Literature DB >> 708489

The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo.

M Potokar, M Schmidt-Dunker.   

Abstract

Three new diphosphonic acids, i.e. compounds containing a P-C-P bond, have been investigated for their ability to inhibit the vitamin D-induced calcification of aortas and kidneys in rats. The compounds were applied orally in various doses. All of the compounds, which had previously been shown to effectively inhibit the in vitro crystallization of apatite, markedly decreased the amount of calcium deposited in aortas and kidneys. One of the new compounds was substantially more effective than ethane-1-hydroxy-1,1-diphosphonic acid (EHDP), which was used as a reference compound. Diphosphonic acids might be used therapeutically in man against soft tissue calcification.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708489     DOI: 10.1016/0021-9150(78)90124-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Effect of ethane-I-hydroxy-I, I-diphosphonate on arterial calcinosis induced by hypervitaminosis D: a morphologic investigation.

Authors:  J G Kingma; P E Roy
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

2.  Effects of diltiazem on suppression and regression of experimental atherosclerosis.

Authors:  M Sugano; Y Nakashima; H Tasaki; M Takasugi; A Kuroiwa; O Koide
Journal:  Br J Exp Pathol       Date:  1988-08

3.  Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation.

Authors:  R E Clark; I Y Christlieb; T B Ferguson; C S Weldon; J P Marbarger; B E Sobel; R Roberts; P D Henry; P A Ludbrook; D Biello; B K Clark
Journal:  Ann Surg       Date:  1981-06       Impact factor: 12.969

4.  Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

Authors:  D M Kramsch; A J Aspen; C S Apstein
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

5.  Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

Authors:  P D Henry; K I Bentley
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

Authors:  Koba A Lomashvili; Marie-Claude Monier-Faugere; Xiaonan Wang; Hartmut H Malluche; W Charles O'Neill
Journal:  Kidney Int       Date:  2009-01-07       Impact factor: 10.612

7.  Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats.

Authors:  P H Reitsma; O L Bijvoet; H Verlinden-Ooms; L J van der Wee-Pals
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.